SpectraMedix Named by CMS as a 2018 MIPS QCDR
eMeasures360™ Streamlines MIPS Reporting
East Windsor, NJ – January 11, 2018 – SpectraMedix announced today that the Center for Medicare and Medicaid Services (CMS) has approved the company’s eMeasures360™ Platform to participate in the Merit-Based Incentive Payment System (MIPS) for 2018 as a Qualified Clinical Data Registry (QCDR). A proven track record of success as a Qualified Registry in both 2016 and 2017 helped to streamline the vetting process in which SpectraMedix demonstrated its ability to calculate MIPS measures and transmit results in the required file formats. QCDRs can report data for individual clinicians or groups on all MIPS performance categories, and also report non-MIPS measures approved by CMS.
Additionally, SpectraMedix is ONC certified to report all 64 eligible provider electronic clinical quality measures (eCQMs) and all 29 eligible hospital eCQMs.
The QCDR reporting option is not limited to measures within the Quality Payment Program and can host a maximum of 30 “non-MIPS” measures approved by CMS for reporting. This option is sought after by many specialty groups or individuals that need to report using standards aligned with their type of care or measures that can be fulfilled by all members of a collaborative.
“With the release of the 2018 MACRA Final Rule, it’s clear that MACRA is not going away anytime soon. The newly-added Cost Measure weight of 10% of the overall score is another hurdle in achieving positive payment adjustments. Our goal is to simplify the process for our customers, anticipating and overcoming hurdles by providing an end-to-end solution that guides them through the entire planning and reporting process,” said Raj Lakhanpal, MD, FACEP, and Chief Executive Officer of SpectraMedix.
eMeasures360™ is a complete solution for MACRA reporting that enables healthcare organizations to capture patient data, calculate measures and report results to CMS to minimize financial penalties and gain maximum incentives. SpectraMedix’s solution also provides measure drill-downs and dashboards to help leadership, providers and analysts evaluate performance and take action to improve quality. Key benefits of eMeasures360™ include:
- The ability to satisfy all MIPS categories and all 243 registry-based MIPS measures
- Systems to extract and harmonize claims, clinical, survey and self-reported data
- A validation process for MIPS measure calculation
- Near real-time performance tracking to monitor and improve scores on a regular basis
- CMS and commercial payer value-based care programs in one platform
eMeasures360™ provides the ability to report a broad range of quality measures including HIQR, PCMH, ACO MSSP, NCQA, CIN, HEDIS, AHRQ and NQF. It also provides a Measure Authoring Tool to rapidly add new and custom measures as needed.
Dr. Lakhanpal concluded the announcement by noting, “MIPS clients can trust SpectraMedix to use all options – including custom answers – to facilitate the data aggregation and reporting process. Anticipating change and utilizing the latest certified quality measures are significant components of the solutions we offer.”
SpectraMedix partners with hospitals, health systems, provider organizations, health information exchanges and payers to improve care delivery and support their transition to value-based payment models. Our proven eMeasures360™ quality management and eureQa360™ population health intelligence solutions provide advanced data integration, quality measurement and population health analytics capabilities to implement initiatives and programs including the MACRA, Medicaid reform programs, Clinically Integrated Networks, ACOs, financial risk modeling, bundled payments and electronic clinical quality measures.
609-336-7733 Ext. 308